relatlimab

Italy

Drugs containing this active substance

  • OPDUALAG

    Opdualag is a medicine used for the treatment of advanced melanoma, a type of skin cancer that can spread to other parts of the body. It is indicated for adults and adolescents aged 12 years and older.

    Form: solution for infusion, concentrate

    Active substance Dosage
    nivolumab -
    relatlimab -

    ATC: L01FY02

    Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG